Media availability


Meet leaders in cancer research, ask questions and discuss innovative science with the experts.

Meet leaders in cancer research, ask questions and discuss innovative science with the experts.

WHAT: Members of the press are cordially invited to meet with the speakers from AACR's Annual Meeting opening plenary session, taking place 8 a.m. PDT, Sunday, April 17, 2005 at the Anaheim Convention Center, Anaheim, Calif.

WHEN: This media availability will follow the plenary session, which ends at 11:30 a.m. PDT

WHERE: AACR Press Briefing Room, second floor, Anaheim Convention Center, Room 211-A

WHO: Participants in the session include:

Michael B. Kastan, M.D., Ph.D., Cancer Center Director and Chairman, Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tenn. Dr. Kastan is a practicing oncologist whose laboratory research focuses on radiation biology, DNA damage and repair, tumor suppressor genes, determinants of chemosensitivity and radiosensitivity, and causes of cancer. Dr. Kastan made the seminal discovery that the p53 tumor suppressor protein participates in cellular responses to DNA damage. More recently, his lab demonstrated how the ATM protein is activated by DNA damage. Dr. Kastan is the 2005 AACR Annual Meeting Chairperson and, as such, he is chairing the opening plenary session, entitled "The Impact of Scientific Discovery on Cancer Diagnosis and Treatment."

Clifton Leaf, executive editor, Fortune Magazine. Mr. Leaf helps oversee the magazine's editorial coverage and staff, and directs Fortune's Wall Street and investing coverage. His March 22, 2004 cover story, "Why We're Losing the War on Cancer (and How to Win It)," generated much discussion in the cancer research community.

Tyler E. Jacks, Ph.D., the David H. Koch Professor of Biology, the Director of the Center for Cancer Research at MIT, and investigator with the Howard Hughes Medical Institute. Dr. Jack's laboratory has pioneered and constructed a series of mutant mouse models of many human cancer types that also have been used to study cancer-associated genes. The topic of Dr. Jacks' talk is "Modeling cancer in the mouse."

Sara A. Courtneidge, Ph.D., Director and Professor in the Cell Adhesion and Extracellular Matrix Department at the Burnham Institute, La Jolla, Calif. Dr. Courtneidge is a leader in the field of signal transduction, with a special focus on Src, a protein tyrosine kinase which is frequently over-expressed in human tumors. Dr. Courtneidge's talk will be "Therapeutic targeting of signaling pathways: progress and promise."

Ronald Levy, M.D., Professor of Medicine, and Chief of the Division of Oncology at Stanford University School of Medicine. He is the Robert K. Summy and Helen K. Summy Professor at Stanford, as well as the Frank and Else Schilling American Cancer Society Clinical Research Professor. Dr. Levy's pathfinding studies of malignant lymphoma and tumors of the immune system led to the development of Rituxan, the first monoclonal antibody approved to treat cancer. Dr. Levy's talk will be "Immunology: From science to therapy."

V. Craig Jordan, Ph.D., D.Sc., Vice President and Scientific Director of the Medical Science Division of the Fox Chase Cancer Center, Philadelphia, Pa. Dr. Jordan is a pharmacologist known as the "father" of the breast cancer drug tamoxifen. Dr. Jordan's talk is titled "Targeting the estrogen receptor to treat and prevent breast cancer."

Daniel A. Haber, M.D., Ph.D., Director and Professor of Medicine at the Massachusetts General Hospital Cancer Center and genetics editor for the New England Journal of Medicine. Dr. Haber is a leader in the discovery of the genetic abnormalities underlying hereditary breast cancer. Today, his laboratory is focusing on the characterization of tumor suppressor genes and the identification of novel genes that confer predisposition to malignancy. His talk will be "Mutations in the epidermal growth factor receptor as predictors of response to tyrosine kinase inhibitors."

AACR Press Room:
Location: Room 209, Anaheim Convention Center
Hours: Saturday, April 16 Tuesday, April 19, 8:00 a.m. to 6:00 p.m.
Wednesday, April 20, 8:00 a.m. to 12:00 noon

Telephone: 714-765-2030
Fax: 714-765-2031
E-mail: [email protected], or [email protected]

Contact/Press Registration:
AACR; Yarissa Ortiz 215-440-9300 [email protected]

Spectrum Science Communications; Kellie Hanzak 202-955-6222 [email protected]

Source: Eurekalert & others

Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
    Published on All rights reserved.